Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

7,989 public trials 1,817 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Recruiting

A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

NCT07005128

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Small-cell Lung Cancer, +9 more
Locations
  • Cancer and Blood Specialists of Arizona Casa Grande, Arizona, United States
  • City of Hope Cancer Center Phoenix Goodyear, Arizona, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • Saint Bernards Medical Center Jonesboro, Arkansas, United States
View all 164 locations
View Trial Details
Recruiting

Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

NCT07168993

Conditions
Disease, Lung Cancer (Diagnosis), Lung Diseases, +8 more
Locations
  • VA Palo Alto Health Care System Palo Alto, California, United States
  • VA Western Colorado Health Care System Grand Junction, Colorado, United States
  • Bay Pines VA Healthcare System Bay Pines, Florida, United States
  • Miami VA Healthcare System Miami, Florida, United States
View Trial Details
Recruiting

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

NCT06047379

Conditions
Adenocarcinoma, Astrocytoma, Brain Diseases, +93 more
Locations
  • Precision NextGen Oncology Beverly Hills, California, United States
  • OPN Healthcare, Inc Glendale, California, United States
  • University of Southern California Los Angeles, California, United States
  • MDR Core Network Boynton Beach, Florida, United States
View Trial Details
Recruiting

Nelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer

NCT07306624

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • The Catholic University of Korea St. Vincent's Hospital Gyeonggi-do, South Korea
  • Kangbuk Samsung Hospital Seoul, South Korea
  • Korea University Anam Hospital Seoul, South Korea
  • Samsung Medical Center Seoul, South Korea
View Trial Details
Recruiting

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

NCT06060613

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +23 more
Locations
  • The Angeles Clinic and Research Institute (Melanoma) Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center (Melanoma/NSCLC) Los Angeles, California, United States
  • Stanford Cancer Institute (Melanoma/NSCLC) Stanford, California, United States
  • Orlando Health Cancer Institute (Melanoma/NSCLC) Orlando, Florida, United States
View Trial Details
Recruiting

Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

NCT07397338

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, CRC, +22 more
Locations
  • Eastern Connecticut Hematology and Oncology Associates Norwich, Connecticut, United States
  • Tennessee Oncology Nashville, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • NEXT Dallas Irving, Texas, United States
View Trial Details
Recruiting

A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

NCT07365319

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Southern Cancer Center, P.C. Daphne, Alabama, United States
  • Los Angeles Cancer Network Glendale, California, United States
  • Rocky Mountain Cancer Centers, LLP Pueblo, Colorado, United States
  • NYU Langone Hospital Long Island Mineola, New York, United States
View Trial Details
Recruiting

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

NCT05652686

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +22 more
Locations
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Yale University Cancer Center New Haven, Connecticut, United States
View all 15 locations
View Trial Details

Related conditions